SCHEMBL8209442

SCHEMBL8209442

NC(=O)N1C(=O)[C@H](c2ccc(Oc3ccccc3)cc2)C[C@@H]1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.43
KCNH2 Q12809 1/20 0.43
SCN3A Q9NY46 1/20 0.43
PARP10 Q53GL7 1/20 0.42
CYP19A1 P11511 1/20 0.40
HTT P42858 1/20 0.40
FFAR1 O14842 4/20 0.39
HPGD P15428 1/20 0.39
SCN4A P35499 1/20 0.39
KYAT1 Q16773 1/20 0.38
KYAT3 Q6YP21 1/20 0.38
AADAT Q8N5Z0 1/20 0.38
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
FFAR2 O15552 1/20 0.37
LMNA P02545 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8209387 0.90 S1PR5 (0.42) FFAR1ALDH1A1LMNAMMP2MMP3
SCHEMBL8213085 0.90 MMP13 (0.46) KCNH2PARP10SCN4AMMP1MMP2
SCHEMBL8210831 0.89 BTK (0.35) KDM1AKCNH2SCN3ACYP19A1HTT
SCHEMBL8209566 0.85 POLB (0.45) KDM1APARP10ALDH1A1SMN1; SMN2MMP1
SCHEMBL8209192 0.85 MMP13 (0.49) KDM1AKCNH2PARP10MMP13NPC1
SCHEMBL8208991 0.85 NPC1 (0.41) KDM1AFFAR1HPGDSMN1; SMN2FFAR2
SCHEMBL8201643 0.84 ALOX5 (0.40) KCNH2PARP10HTTFFAR1MMP13
SCHEMBL8211593 0.84 ALOX5 (0.52) KCNH2SCN3APARP10HTTMMP13
SCHEMBL8211587 0.82 S1PR1 (0.42) KDM1AFFAR1ALDH1A1
SCHEMBL8209631 0.77 S1PR5 (0.51) KDM1AKCNH2PARP10NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114361-A INHIBITORS OF MATRIX METALLOPROTEINASES AND REPROLYSIN; ADMINISTERING TO TREAT CONDITIONS WHICH CAN BE TREATED BY THE INHIBITION OF THESE ENZYMES PFIZER INC. (US) 2000-09-05 US claimed